Table 5.
Serum 25(OH)D concentrations and COVID-19 severity.
| 25(OH)D (nmol/L) | COVID-19-Related Death | Severe COVID-19, Including Death | ICU Admission | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Time points * | |||||||||
| T1 (n = 37) |
No | Yes | p value ** | No | Yes | p value ** | No | Yes | p value ** |
| 25(OH)D (IQR) | 72 (56–86) |
62 (52–70) |
0.376 | 74 (56–86) |
67 (52–72) |
0.374 | 71 (56–85) |
63 (50–80) |
0.520 |
| n | 31 | 6 | 27 | 10 | 32 | 5 | |||
| T2 (n = 69) |
No | Yes | p value ** | No | Yes | p value ** | No | Yes | p value ** |
| 25(OH)D (IQR) | 61 (35–85) |
53 (40–107) |
0.694 | 60 (37–85) |
68 (33–94) |
0.809 | 60 (37–89) |
59 (28–75) |
0.469 |
| n | 61 | 8 | 53 | 16 | 63 | 6 | |||
* Time points: T1, up to three months before the SARS-CoV-2 infection onset; T2, during the first week of hospitalisation. ** Mann–Whitney U test.